Shehab Mohamed: Real-World Evidence on Maternal and Neonatal Outcomes in ITP
Shehab Mohamed, Hematologist at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Health Science Reports, adding:
“Here we go!
Newly published study in Health Science Reports:
Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five-Year Single-Center Cross-Sectional Study
At our center, we always strive to reflect on our real-world clinical experience and translate it into evidence that can help improve patient care. This study represents our 5-year experience managing pregnant patients with immune thrombocytopenia (ITP) at Hamad Medical Corporation, Qatar.
Key findings:
- Most pregnancies were uncomplicated
- Maternal complications occurred in 19.8% of cases
- Neonatal complications occurred in 12.4% of cases
- Pregnancy-onset ITP was associated with higher complication rates than pre-pregnancy ITP
- Steroids and IVIG remained effective first-line therapies
- Selected refractory cases were successfully managed with thrombopoietin receptor agonists
One particularly reassuring observation was that our maternal and neonatal outcomes closely mirrored those reported in contemporary international real-world studies, supporting the quality of care delivered in our center and reinforcing the generalizability of current evidence to our diverse Middle Eastern population.
These findings highlight the importance of early recognition, multidisciplinary collaboration, and individualized management in optimizing outcomes for both mothers and newborns.
Grateful to all co-authors, collaborators, and patients who contributed to this work.”
Title: Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five-Year Single-Center Cross-Sectional Study
Authors: Sara Elkorashi, Hassan Magboul, Abdulrahman F. Al-Mashdali, Mohammed Alnajjar, Naela AlMallahi, Elmustafa Abdalla, Dina Sameh Soliman, Sara Aldali, Manar Elsheikh, Honar Cherif, Shehab F. Mohamed
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 18, 2026, 19:53Astha Thakkar: What Is the Most Important Test for a Bleeding Disorder?
-
Jun 18, 2026, 19:51Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
-
Jun 18, 2026, 19:49Ana Rita Santos: Cost-Effectiveness of Chatbot-Supported Remote Monitoring for Anticoagulation Management
-
Jun 18, 2026, 19:46Angela Fan: Highlighting the Significant Burden Faced by Patients Living With PV
-
Jun 18, 2026, 15:29Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
-
Jun 18, 2026, 15:13Youssef Afifi: The Thrombocytosis–Bleeding Paradox
-
Jun 18, 2026, 15:06Nihala Sharin E A: The Vital Role of Hematology in the Medical Laboratory
-
Jun 18, 2026, 14:59Maeve Crowley: Shining a Light on Venous Thromboembolism Trends in Ireland
-
Jun 18, 2026, 14:52Samwel Mikaye: Why Early Recognition of Pulmonary Embolism Matters